icon-folder.gif   Conference Reports for NATAP  
 
  International Symposium on Viral Hepatitis and Liver Disease
March 20th - 24th 2009
Washington, DC
Back grey_arrow_rt.gif
 
 
 
Five-Years of Continuous Entecavir for Nucleoside-Naive HBeAg(+) Chronic Hepatitis B: Results from Studies ETV-022/-901
 
 
  Reported by Jules Levin
13th ISVHLD March 20-24 2009 Wash DC
 
S Han1, TT Chang2, YC Chao3, SK Yoon4, RG Gish5, H Cheinquer6, GE Kitis7, H Zhang8 and U Iloeje8 1. Division of Digestive Disease, UCLA School Of Medicine, LA, California, USA; 2. Department of Internal Medicine, National Cheng Kung University Medical College, Tainan, Taiwan; 3. Neuro-Medical Scientific Center Departments, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan; 4. Kangnam St. Mary's Hospital, Seoul, Korea; 5. Division of Hepatology and Complex GI, California Pacific Medical Center, San Francisco, California, USA; 6. Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil; 7. Department of Gastroenterology, Georgios Papanikolaou Hospital, Thessaloniki, Greece; 8. Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, USA

Conclusion-1.gif

Summary-2.gif

PopStudy-3.gif

AnalEfficary-4.gif

Demo-5.gif

Exposure-6.gif

Achieving-7.gif

serologic-8.gif

cumulat-9.gif

Tenney-10.gif